In another pioneering initiative, the company enhances the reliability of diagnostic reports.
Oropouche fever, caused by the Orthobunyavirus oropoucheense (OROV) arbovirus, is a growing public health concern. It not only has the potential to trigger outbreaks but also presents symptoms that can easily be confused with those of other viral infections such as Zika, Chikungunya, and Dengue.
This symptomatic similarity can complicate diagnosis and treatment. Therefore, ensuring accurate diagnostic reports is crucial for effective surveillance and control of the disease, helping to prevent new infections and outbreaks. According to the technical note from the Brazilian Ministry of Health, as of July 7, 2024, 7,044 cases have been confirmed in the country.
Attentive to the needs of the diagnostic sector, Controllab, in another pioneering initiative, invites laboratories to participate in the first round of the Proficiency Testing for Molecular Biology – Oropouche Fever.
The Proficiency Testing (PT) follows the criteria of ABNT NBR ISO/IEC 17043 and will be sent on September 9. The round will be free of charge for laboratories that express their interest through this link by the end of August.
Suspected cases need to be quickly identified to prevent the spread of the disease and the overload on the healthcare system. This helps avoid self-medication, worsening symptoms, hospitalizations, or deaths.
Importance of monitoring and evaluating analytical routines
Laboratory routines require continuous monitoring and periodic evaluation, as they play a crucial role in the processes of detection, assessment, response, notification, and monitoring of public health events.
The Proficiency Testing, also known as External Quality Control, is an effective tool for determining the analytical performance of the laboratory, helping to standardize new diagnostic tests for the disease.
Additionally, it is a necessary requirement for laboratory accreditation processes (ISO 15189, ISO 17025, PALC-SBPC/ML, DICQ-SBAC, etc.) and regulatory bodies.
Join us!
